Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4 Biotech Growth Stocks at a Reasonable Price
Seeking Alpha
Friday, October 22, 2010 - 10:50am
tags:
Teva Pharmaceuticals, Gilead Sciences, Cephalon, Cubist Pharmaceuticals
Lilly Diabetes Drug Setbacks May Spur Biotech Shopping Spree Beyond Amylin
Bloomberg
Friday, October 22, 2010 - 7:26am
tags:
diabetes, Amylin, Eli Lilly, Cephalon, M&A, Endo, Bydureon, Byetta
FDA to Decide Obesity Drug Lorcaserin's Fate
WSJ Online
Friday, October 22, 2010 - 7:25am
tags:
FDA, obesity, Arena Pharmaceuticals
[video] Two Ways To Fix The FDA
Forbes
Thursday, October 21, 2010 - 10:09pm
tags:
FDA
Merck says shingles vaccine shows positive results
Yahoo/AP
Thursday, October 21, 2010 - 10:09pm
tags:
shingles, vaccines, Merck
Alexion's Soliris meets key goals in studies
Yahoo/AP
Thursday, October 21, 2010 - 4:18pm
tags:
Alexion, Soliris
Alcon Beats, Improves Outlook
Yahoo/Zacks.com
Thursday, October 21, 2010 - 4:16pm
tags:
earnings, Alcon
Investors to Eli Lilly: Buy or Be Bought
Minyanville
Thursday, October 21, 2010 - 4:15pm
tags:
investors, M&A, Eli Lilly
Get A Birdie (Or Eagle) With Par Pharmaceutical
Forbes
Thursday, October 21, 2010 - 4:14pm
tags:
Par Pharmaceutical
Abbott Just Can't Get Any Love
Motley Fool
Thursday, October 21, 2010 - 4:13pm
tags:
Abbott Laboratories, earnings
FDA warns of heart risk with HIV drug combination
Yahoo/AP
Thursday, October 21, 2010 - 12:29pm
tags:
HIV, FDA, Roche, Abbott Laboratories, Norvir, Invirase
Woodcock: FDA may tighten generic-drug rules
Fierce Pharma
Thursday, October 21, 2010 - 11:49am
tags:
generics, FDA
Acorda Hopes to Meet Huge Need in Challenging Stroke Market
Seeking Alpha
Thursday, October 21, 2010 - 11:16am
tags:
Acorda Therapeutics, Athersys
Glaxo Receives Federal Subpoena About Avandia
Pharmalot
Thursday, October 21, 2010 - 11:15am
tags:
GSK, Avandia
US FDA backs Roche's Herceptin in stomach cancer
Reuters, UK
Thursday, October 21, 2010 - 11:13am
tags:
FDA, Roche, Herceptin, stomach cancer
FDA Calls for New Warnings on Some Prostate Cancer Drugs
Yahoo/Health Day
Thursday, October 21, 2010 - 11:12am
tags:
FDA, prostate cancer, Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, Zoladex, GnRH antagonists
What You Need to Know About Margins at Pfizer
Motley Fool
Thursday, October 21, 2010 - 11:08am
tags:
Pfizer, margins
Cardiome shares battered by clinical trial halt
Marketwatch
Thursday, October 21, 2010 - 11:08am
tags:
clinical trials, Cardiome, Vernakalant
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thursday, October 21, 2010 - 11:07am
tags:
Amylin, diabetes, Alkermes, Eli Lilly, Bydureon
GlaxoSmithKline profit down 3.5%, dividend raised
Marketwatch
Thursday, October 21, 2010 - 10:52am
tags:
GSK, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.